RNF5 (RMA1, NG2/G16) is a small (180 aa) tail-anchored RING-type E3 ubiquitin-protein ligase (EC 2.3.2.27) embedded in the endoplasmic reticulum membrane via two C-terminal transmembrane helices, with an N-terminal cytosolic C3HC4 RING domain (catalytic Cys-42) that recruits ubiquitin-charged E2 enzymes (notably the UBE2D/UbcH5 family and UBE2N/Ubc13). RNF5 is one of the founding mammalian ER-anchored ERAD ubiquitin ligases. Together with the E2 UBE2J1/Ubc6e and Derlin-1 it recognizes folding defects in membrane proteins co-translationally and assembles K48-linked polyubiquitin chains that commit misfolded clients such as CFTR and the disease-associated CFTR-deltaF508 mutant to retrotranslocation and proteasomal degradation; it functions partly redundantly with its close paralog RNF185, with which it forms an E3 ligase module central to CFTR degradation. Beyond canonical ERAD, RNF5 has documented ligase-dependent regulatory roles that use distinct chain topologies and substrates. It builds non-degradative K63-linked chains on the ERAD adaptor JKAMP/JAMP to limit its recruitment of proteasome and p97/VCP components; it ubiquitinates and degrades the innate-immune adaptor STING1/MITA at mitochondria to dampen antiviral type I interferon responses; it controls basal autophagy by regulating the stability of a membrane pool of the cysteine protease ATG4B; and it ubiquitinates paxillin to influence cell motility. RNF5 is widely expressed, and although localized predominantly to membranes (with reported plasma-membrane and mitochondrial-membrane pools), its ER-membrane localization underlies its core ERAD ligase function.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0061630
ubiquitin protein ligase activity
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic assignment of RING-type ubiquitin ligase activity, the core molecular function of RNF5, conserved across the RNF5/RNF185 family.
Reason: Core molecular function; supported experimentally (EC 2.3.2.27; C42S abolishes activity) and across the family.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
|
|
GO:0036503
ERAD pathway
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetic assignment of involvement in ER-associated degradation, the core biological process of RNF5 as an ER-anchored ERAD ligase.
Reason: Core biological process; directly supported by IMP evidence (CFTR/CFTR-deltaF508 degradation) and conserved in the family.
Supporting Evidence:
PMID:24019521
Cystic fibrosis transmembrane conductance regulator (CFTR) is one ERAD substrate targeted to co-translational degradation by the E3 ligase RNF5/RMA1
|
|
GO:0044390
ubiquitin-like protein conjugating enzyme binding
|
IBA
GO_REF:0000033 |
KEEP AS NON CORE |
Summary: RNF5 binds ubiquitin-conjugating (E2) enzymes, including the UBE2D/UbcH5 family and UBE2N/Ubc13, as part of its catalytic cycle. This is informative but ancillary to the ligase activity itself.
Reason: Accurately reflects E2 binding (UBE2D1/UBE2D2, UBE2N) required for catalysis, but is a mechanistic subsidiary of the core ubiquitin ligase activity.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
May function together with E2 ubiquitin-conjugating enzymes UBE2D1/UBCH5A and UBE2D2/UBC4
|
|
GO:0005783
endoplasmic reticulum
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based electronic assignment of ER localization, consistent with RNF5's ER-membrane site of ERAD function.
Reason: Correct compartment; redundant with the more specific ER membrane annotations and IDA (HPA) evidence.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}
|
|
GO:0005789
endoplasmic reticulum membrane
|
IEA
GO_REF:0000044 |
ACCEPT |
Summary: Electronic transfer of ER membrane localization from the UniProt subcellular location; this is the core compartment for RNF5's ERAD ligase function.
Reason: Correct core localization; RNF5 is a tail-anchored ER membrane protein, supported experimentally (EXP, PMID:19285439).
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}
|
|
GO:0005886
plasma membrane
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: Electronic transfer of plasma membrane localization from the original cloning study (PMID:9533025). A real but secondary localization not tied to the core ERAD function.
Reason: Reported in the early cloning paper but the functionally dominant compartment for RNF5 is the ER membrane; plasma membrane pool is peripheral.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Cell membrane {ECO:0000269|PubMed:9533025}
|
|
GO:0006511
ubiquitin-dependent protein catabolic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based electronic assignment of ubiquitin-dependent protein catabolism, a parent process consistent with RNF5's ERAD role.
Reason: Correct but generic; the specific GO:0036503 (ERAD pathway) better captures the core biological role.
Supporting Evidence:
PMID:24019521
degraded by the ubiquitin-proteasome pathway through a process called ER-associated degradation (ERAD)
|
|
GO:0031966
mitochondrial membrane
|
IEA
GO_REF:0000044 |
KEEP AS NON CORE |
Summary: Electronic transfer of mitochondrial membrane localization, reflecting the antiviral STING1/MITA study in which RNF5 acts at mitochondria. A real but secondary, immunity-related localization.
Reason: Supported by PMID:19285439 (MITA ubiquitination at mitochondria) but represents a secondary, context-specific role distinct from the core ER-membrane ERAD function.
Supporting Evidence:
PMID:19285439
virus-induced ubiquitination and degradation of MITA by RNF5 occurred at the mitochondria
|
|
GO:0036503
ERAD pathway
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA machine-learning electronic assignment of the ERAD pathway, redundant with the experimentally supported core process.
Reason: Correct core biological process; redundant with IMP and IBA evidence.
Supporting Evidence:
PMID:24019521
Cystic fibrosis transmembrane conductance regulator (CFTR) is one ERAD substrate targeted to co-translational degradation by the E3 ligase RNF5/RMA1
|
|
GO:0044322
endoplasmic reticulum quality control compartment
|
IEA
GO_REF:0000108 |
KEEP AS NON CORE |
Summary: Inter-ontology logical inference placing RNF5 in the ER quality control compartment, a plausible localization derived from its ERAD role.
Reason: Plausible localization inferred from the ERAD/ERQC link, but not directly demonstrated; the core localization annotation is ER membrane.
Supporting Evidence:
PMID:24019521
hosts a machinery called ERQC for ER quality control
|
|
GO:0061630
ubiquitin protein ligase activity
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Combined automated electronic assignment of the core RING E3 ligase activity, consistent with EC 2.3.2.27 and experimental evidence.
Reason: Correct core molecular function; redundant with EXP/IBA evidence.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
EC=2.3.2.27
|
|
GO:1904380
endoplasmic reticulum mannose trimming
|
IEA
GO_REF:0000117 |
REMOVE |
Summary: ARBA machine-learning assignment of ER mannose trimming. RNF5 is a ubiquitin ligase and does not trim mannose; this is a pathway-adjacency over-annotation propagated from the ERAD/ERQC context.
Reason: RNF5 has no glycosidase/mannosidase activity; mannose trimming is performed by EDEM/ER mannosidases, not by the E3 ligase. This electronic inference is biologically incorrect.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
|
|
GO:0005515
protein binding
|
IPI
PMID:12861019 RNF5, a RING finger protein that regulates cell motility by ... |
KEEP AS NON CORE |
Summary: IntAct interaction with paxillin (PXN), a functionally meaningful RNF5 substrate, but the bare protein binding term is uninformative.
Reason: Records a real substrate interaction (PXN) but bare protein binding is uninformative per curation guidelines.
Supporting Evidence:
PMID:12861019
the human homologue of RNF5 associates with the amino-terminal domain of paxillin
|
|
GO:0005515
protein binding
|
IPI
PMID:14667819 Analysis of a high-throughput yeast two-hybrid system and it... |
KEEP AS NON CORE |
Summary: High-throughput yeast two-hybrid interactions (e.g. ABHD16A, UBE2 enzymes). Bare protein binding is uninformative.
Reason: Records real IntAct interactions but bare protein binding is uninformative and not a core function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; O95870: ABHD16A
|
|
GO:0005515
protein binding
|
IPI
PMID:16901789 Sequential quality-control checkpoints triage misfolded cyst... |
KEEP AS NON CORE |
Summary: Interaction with CFTR captured in the sequential-triage ERAD study; CFTR is a key RNF5 ERAD substrate. Bare protein binding is uninformative.
Reason: Records the functionally important RNF5-CFTR interaction, but bare protein binding is uninformative; the substrate relationship is captured by the ERAD process annotations.
Supporting Evidence:
PMID:16901789
an ER membrane-associated ubiquitin ligase complex containing the E3 RMA1, the E2 Ubc6e, and Derlin-1
|
|
GO:0005515
protein binding
|
IPI
PMID:19549727 Analysis of the human E2 ubiquitin conjugating enzyme protei... |
KEEP AS NON CORE |
Summary: E2 ubiquitin-conjugating enzyme interaction network capturing RNF5 binding to multiple UBE2D/UBE2E/UBE2W E2s. Bare protein binding is uninformative.
Reason: Real E2 interactions relevant to catalysis but bare protein binding is uninformative; E2 binding is captured by GO:0044390.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; P51668: UBE2D1
|
|
GO:0005515
protein binding
|
IPI
PMID:20152160 Crystal structure of UbcH5b~ubiquitin intermediate: insight ... |
KEEP AS NON CORE |
Summary: Interaction with the E2 UBE2D2/UbcH5b from a structural study of the E2~Ub conjugate. Bare protein binding is uninformative.
Reason: Real E2 interaction but bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; P62837: UBE2D2
|
|
GO:0005515
protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
KEEP AS NON CORE |
Summary: Large-scale interactome map capturing numerous RNF5 partners (including SLC transporters, RNF185, SEC22A). Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative and not a core function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q96GF1: RNF185
|
|
GO:0005515
protein binding
|
IPI
PMID:25759021 Regulation of glutamine carrier proteins by RNF5 determines ... |
KEEP AS NON CORE |
Summary: Interactions with glutamine carrier proteins (SLC1A5, SLC38A2) relevant to RNF5's role in breast cancer ER-stress response. Bare protein binding is uninformative.
Reason: Records real substrate/carrier interactions but bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q15758: SLC1A5
|
|
GO:0005515
protein binding
|
IPI
PMID:26618866 ∆F508 CFTR interactome remodelling promotes rescue of cystic... |
KEEP AS NON CORE |
Summary: Interaction with CFTR from a deltaF508 CFTR interactome-remodeling study. Bare protein binding is uninformative.
Reason: Real CFTR interaction relevant to ERAD but bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; P13569: CFTR
|
|
GO:0005515
protein binding
|
IPI
PMID:31515488 Extensive disruption of protein interactions by genetic vari... |
KEEP AS NON CORE |
Summary: Interaction captured in a study of variant-driven interactome disruption. Bare protein binding is uninformative.
Reason: High-throughput interaction; bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q969T4: UBE2E3
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
KEEP AS NON CORE |
Summary: Binary interactome reference map capturing many RNF5 membrane-protein partners. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q9Y5U4: INSIG2
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
KEEP AS NON CORE |
Summary: Interactions (e.g. OPTN, UBE2K) from a neurodegenerative-disease interactome study. Bare protein binding is uninformative.
Reason: High-throughput interaction; bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q96CV9: OPTN
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
KEEP AS NON CORE |
Summary: Cell-specific interactome capturing RNF5 partners including RNF185 and RHBDD1. Bare protein binding is uninformative.
Reason: High-throughput interactome; bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q96GF1: RNF185
|
|
GO:0005515
protein binding
|
IPI
PMID:36012204 Differential CFTR-Interactome Proximity Labeling Procedures ... |
KEEP AS NON CORE |
Summary: Proximity-labeling interaction with CFTR identifying enrichment in SLC transporters. Bare protein binding is uninformative.
Reason: Real CFTR/SLC interactions but bare protein binding is uninformative.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; P13569: CFTR
|
|
GO:0042802
identical protein binding
|
IPI
PMID:25416956 A proteome-scale map of the human interactome network. |
KEEP AS NON CORE |
Summary: RNF5 self-interaction captured in a proteome-scale interactome. Reflects homo-association seen in screens.
Reason: Documents RNF5 self-association (IntAct EBI-348482 with itself) but is peripheral to the core ligase function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q99942: RNF5
|
|
GO:0042802
identical protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
KEEP AS NON CORE |
Summary: RNF5 self-interaction captured in the binary interactome reference map.
Reason: Documents RNF5 self-association but is peripheral to the core ligase function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Q99942; Q99942: RNF5
|
|
GO:0016020
membrane
|
IEA
GO_REF:0000107 |
KEEP AS NON CORE |
Summary: Ortholog-based electronic assignment of generic membrane localization, a parent of the specific ER membrane localization.
Reason: Correct but generic; subsumed by the more specific ER membrane localization.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Multi-pass membrane protein
|
|
GO:0055085
transmembrane transport
|
TAS
Reactome:R-HSA-382556 |
REMOVE |
Summary: Reactome pathway-level annotation (ABC-family transport). RNF5 is a ubiquitin ligase, not a transporter; this reflects pathway context (CFTR/ABC transport) bleed-through.
Reason: RNF5 does not mediate transmembrane transport; it is an E3 ligase acting on transporter substrates such as CFTR. The transport annotation is a pathway-adjacency artifact, not a direct function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
|
|
GO:0016567
protein ubiquitination
|
IEA
GO_REF:0000041 |
KEEP AS NON CORE |
Summary: UniPathway-derived general protein ubiquitination process, a parent of the specific ERAD-associated ubiquitination RNF5 performs.
Reason: Correct but generic; the specific ERAD pathway and K48/K63 ubiquitination annotations better capture the role.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
PATHWAY: Protein modification; protein ubiquitination.
|
|
GO:0061630
ubiquitin protein ligase activity
|
TAS
Reactome:R-HSA-8866546 |
ACCEPT |
Summary: Reactome curation of RNF5 (with RNF185) ubiquitinating misfolded CFTR; captures the core ligase activity.
Reason: Correct core molecular function in the CFTR ERAD reaction.
Supporting Evidence:
PMID:24019521
identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
|
|
GO:0061630
ubiquitin protein ligase activity
|
TAS
Reactome:R-HSA-8867288 |
ACCEPT |
Summary: Reactome curation of the ERAD E3 ligase ubiquitinating an unfolded glycoprotein substrate; captures the core ligase activity.
Reason: Correct core molecular function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
|
|
GO:0005783
endoplasmic reticulum
|
IDA
GO_REF:0000052 |
ACCEPT |
Summary: Direct immunofluorescence (HPA) evidence for ER localization, consistent with RNF5's ER-membrane ERAD function.
Reason: IDA-supported ER localization agrees with the documented ER-membrane site of action.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}
|
|
GO:0005789
endoplasmic reticulum membrane
|
EXP
PMID:19285439 The ubiquitin ligase RNF5 regulates antiviral responses by m... |
ACCEPT |
Summary: Experimental evidence that RNF5 localizes to the ER membrane; the core compartment for its ERAD ligase activity.
Reason: Core localization with direct experimental support.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005886
plasma membrane
|
EXP
PMID:9533025 Cloning, expression and mapping of a novel RING-finger gene ... |
KEEP AS NON CORE |
Summary: Experimental localization to the plasma membrane reported in the original cloning study. A real but secondary localization.
Reason: Documented in the cloning paper but the functionally dominant compartment is the ER membrane; plasma-membrane pool is peripheral to the core ERAD role.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Predominantly located in the plasma membrane, with some localization occurring within cytoplasmic organelles
|
|
GO:0031966
mitochondrial membrane
|
EXP
PMID:19285439 The ubiquitin ligase RNF5 regulates antiviral responses by m... |
KEEP AS NON CORE |
Summary: Experimental localization to the mitochondrial membrane, where RNF5 ubiquitinates STING1/MITA during antiviral responses. A real but secondary, immunity-related localization.
Reason: Directly supported (PMID:19285439) but a secondary compartment for a context-specific immune role, not the core ER ERAD function.
Supporting Evidence:
PMID:19285439
virus-induced ubiquitination and degradation of MITA by RNF5 occurred at the mitochondria
|
|
GO:0061630
ubiquitin protein ligase activity
|
EXP
PMID:19269966 Regulation of endoplasmic reticulum-associated degradation b... |
ACCEPT |
Summary: Experimental demonstration of RNF5 ubiquitin ligase activity (RING-dependent ubiquitination of JAMP). Core molecular function.
Reason: Core molecular function with direct experimental support; WT but not RING-mutant RNF5 ubiquitinates substrate.
Supporting Evidence:
PMID:19269966
Ectopically expressed JAMP was efficiently ubiquitinated in vivo by WT but not the RING mutant form of RNF5
|
|
GO:0061630
ubiquitin protein ligase activity
|
EXP
PMID:19285439 The ubiquitin ligase RNF5 regulates antiviral responses by m... |
ACCEPT |
Summary: Experimental demonstration of RNF5 ligase activity ubiquitinating STING1/MITA. Core molecular function.
Reason: Core molecular function with direct experimental support.
Supporting Evidence:
PMID:19285439
RNF5 targeted MITA at Lys150 for ubiquitination and degradation after viral infection
|
|
GO:0061630
ubiquitin protein ligase activity
|
EXP
PMID:23093945 Regulation of ATG4B stability by RNF5 limits basal levels of... |
ACCEPT |
Summary: Experimental demonstration of RNF5 ligase activity controlling ATG4B ubiquitination and stability. Core molecular function.
Reason: Core molecular function with direct experimental support.
Supporting Evidence:
PMID:23093945
the membrane-associated E3 ligase RNF5 regulates basal levels of autophagy by controlling the stability of a select pool of the cysteine protease ATG4B
|
|
GO:0006511
ubiquitin-dependent protein catabolic process
|
IGI
PMID:24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associa... |
ACCEPT |
Summary: Genetic-interaction evidence (with RNF185) that RNF5 drives ubiquitin-dependent degradation of CFTR; redundant depletion blocks CFTR-deltaF508 turnover.
Reason: Supported by the RNF5/RNF185 co-depletion experiments; consistent with the core ERAD/proteasomal degradation role.
Supporting Evidence:
PMID:24019521
simultaneous depletion of RNF5 and RNF185 profoundly blocks CFTRΔF508 degradation not only during translation but also after synthesis is complete
|
|
GO:0036503
ERAD pathway
|
IMP
PMID:24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associa... |
ACCEPT |
Summary: Mutant-phenotype evidence that RNF5 is required for ERAD of CFTR/CFTR-deltaF508. Core biological process.
Reason: Core biological process with direct experimental (IMP) support from depletion experiments.
Supporting Evidence:
PMID:24019521
simultaneous depletion of RNF5 and RNF185 profoundly blocks CFTRΔF508 degradation
|
|
GO:0061630
ubiquitin protein ligase activity
|
TAS
PMID:24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associa... |
ACCEPT |
Summary: Author statement of RNF5 ubiquitin ligase activity in CFTR ERAD. Core molecular function.
Reason: Correct core molecular function.
Supporting Evidence:
PMID:24019521
targeted to co-translational degradation by the E3 ligase RNF5/RMA1
|
|
GO:1904380
endoplasmic reticulum mannose trimming
|
TAS
Reactome:R-HSA-901032 |
REMOVE |
Summary: Reactome ERQC pathway annotation. RNF5 does not perform mannose trimming; this is pathway-adjacency over-annotation.
Reason: RNF5 is an E3 ligase with no mannosidase activity; ER mannose trimming is carried out by ER mannosidases/EDEMs. The annotation conflates pathway membership with direct activity.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
|
|
GO:0044877
protein-containing complex binding
|
IPI
PMID:24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associa... |
KEEP AS NON CORE |
Summary: RNF5 binds a protein complex (ERAD machinery) in the CFTR degradation study. More informative than bare protein binding but still ancillary.
Reason: Reflects association with the ERAD E3 module/machinery; supportive of, but subsidiary to, the core ligase and ERAD-process annotations.
Supporting Evidence:
PMID:24019521
identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866542 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization within CFTR ERAD reactions. Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866546 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (RNF5/RNF185 ubiquitinate misfolded CFTR). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866551 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (CFTR binds ERAD machinery). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866854 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (CFTR F508del translocation). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866856 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (RNF5/RNF185 ubiquitinate CFTR F508del). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8866857 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (CFTR F508del binds ERAD machinery). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-8867288 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization in an ERAD ubiquitination reaction. Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9931264 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (CD274/PD-L1 ERAD transport). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9931298 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (ubiquitination of CD274 by ERAD complex). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005789
endoplasmic reticulum membrane
|
TAS
Reactome:R-HSA-9931313 |
ACCEPT |
Summary: Reactome curation of RNF5 ER membrane localization (p-CD274 binds ERAD complex). Core compartment.
Reason: Correct core localization; redundant with experimental evidence.
Supporting Evidence:
PMID:19285439
Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
|
|
GO:0005515
protein binding
|
IPI
PMID:24019521 RNF185 is a novel E3 ligase of endoplasmic reticulum-associa... |
KEEP AS NON CORE |
Summary: Interaction captured in the RNF185/RNF5 CFTR ERAD study. Bare protein binding is uninformative.
Reason: Real interaction within the ERAD module but bare protein binding is uninformative.
Supporting Evidence:
PMID:24019521
identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
|
|
GO:0030163
protein catabolic process
|
IMP
PMID:19285439 The ubiquitin ligase RNF5 regulates antiviral responses by m... |
KEEP AS NON CORE |
Summary: Mutant-phenotype evidence that RNF5 drives degradation of a target protein (STING1/MITA). A parent of the more specific ubiquitin-dependent catabolic/ERAD process.
Reason: Correct but generic relative to the specific ERAD and K48-ubiquitination annotations; here the catabolic target is the immune adaptor MITA.
Supporting Evidence:
PMID:19285439
RNF5 targeted MITA at Lys150 for ubiquitination and degradation after viral infection
|
|
GO:0070936
protein K48-linked ubiquitination
|
IDA
PMID:19285439 The ubiquitin ligase RNF5 regulates antiviral responses by m... |
ACCEPT |
Summary: Direct evidence that RNF5 builds K48-linked polyubiquitin chains (degradative topology) on STING1/MITA. This degradative topology is also used on CFTR.
Reason: Directly demonstrated K48-linked ubiquitination, the canonical degradative topology underlying RNF5's ERAD and MITA-degradation roles.
Supporting Evidence:
PMID:19269966
CFTR ubiquitination occurred at the canonical Lys-48 topology
|
|
GO:0004842
ubiquitin-protein transferase activity
|
IDA
PMID:19269966 Regulation of endoplasmic reticulum-associated degradation b... |
ACCEPT |
Summary: Direct evidence of ubiquitin-protein transferase activity, a parent of the specific RING-type ubiquitin ligase activity.
Reason: Correct general molecular function; the specific GO:0061630 captures the RING E3 ligase activity.
Supporting Evidence:
PMID:19269966
Ectopically expressed JAMP was efficiently ubiquitinated in vivo by WT but not the RING mutant form of RNF5
|
|
GO:0005515
protein binding
|
IPI
PMID:19269966 Regulation of endoplasmic reticulum-associated degradation b... |
KEEP AS NON CORE |
Summary: Interaction with JKAMP/JAMP, a functionally important RNF5 substrate/partner at the ER membrane. Bare protein binding is uninformative.
Reason: Records the real RNF5-JAMP interaction but bare protein binding is uninformative.
Supporting Evidence:
PMID:19269966
RNF5 associates with JAMP in the ER membrane
|
|
GO:0036503
ERAD pathway
|
IMP
PMID:19269966 Regulation of endoplasmic reticulum-associated degradation b... |
ACCEPT |
Summary: Mutant-phenotype evidence linking RNF5 to ERAD, here via regulation of the ERAD adaptor JAMP. Core biological process.
Reason: Core biological process; RNF5 modulates ERAD both by direct substrate ubiquitination and by K63-regulation of JAMP.
Supporting Evidence:
PMID:19269966
RNF5 is a ubiquitin ligase anchored to the ER membrane implicated in ERAD via ubiquitination of misfolded proteins
|
|
GO:0070534
protein K63-linked ubiquitination
|
IDA
PMID:19269966 Regulation of endoplasmic reticulum-associated degradation b... |
ACCEPT |
Summary: Direct evidence that RNF5 builds non-degradative K63-linked polyubiquitin chains on JAMP (Ubc13/UBE2N-dependent), a regulatory rather than degradative modification.
Reason: Directly demonstrated K63-linked ubiquitination, establishing RNF5's capacity for non-canonical regulatory ubiquitination distinct from K48 degradative chains.
Supporting Evidence:
PMID:19269966
These findings establish that RNF5 mediates Lys-63-based polyubiquitination of JAMP
|
|
GO:0008270
zinc ion binding
|
TAS
PMID:9533025 Cloning, expression and mapping of a novel RING-finger gene ... |
KEEP AS NON CORE |
Summary: The C3HC4 RING domain coordinates zinc as a structural requirement for the ligase fold. A structural attribute supporting, not equal to, the ligase activity.
Reason: Accurate structural feature of the RING domain (residues 27-68) but subsidiary to the informative ubiquitin ligase activity; not a standalone core function.
Supporting Evidence:
file:human/RNF5/RNF5-uniprot.txt
RING-type
|
Q: What determines RNF5 substrate selectivity and chain-topology choice (K48 degradative on CFTR/MITA vs K63 regulatory on JAMP), and which E2 partner (UBE2D vs UBE2N) is decisive in each case?
Q: To what extent are RNF5's antiviral (STING1/MITA) and autophagy (ATG4B) roles separable from its core ER ERAD function, and do they require distinct subcellular pools?
Experiment: Reconstitute ERAD ubiquitination of CFTR-deltaF508 in vitro with purified RNF5, RNF185, UBE2J1/Ubc6e and Derlin-1 to map lysine sites and ubiquitin-chain linkage on the substrate and to dissect RNF5/RNF185 redundancy.
Experiment: Generate RNF5 and RNF5/RNF185 double-knockout cells and perform quantitative ubiquitinome/proteome profiling under basal and ER-stress conditions to define the endogenous ERAD substrate repertoire and the degree of paralog redundancy.
The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested target is human RNF5 (ring finger protein 5), UniProt Q99942, also known as RMA1. Recent CFTR/ERAD and innate-immunity literature consistently describes RNF5 as an ER-anchored/ER-embedded RING E3 ubiquitin ligase with C-terminal transmembrane segment(s), matching the UniProt-provided identity and domain architecture (RING finger with membrane anchor). (okiyoneda2024targetingubiquitinationmachinery pages 4-7, brusa2023innovativestrategytoward pages 9-11, kamada2024herc3facilitateserad pages 1-2)
RNF5 functions as an E3 ubiquitin ligase, i.e., an enzyme that catalyzes transfer of ubiquitin from an E2 enzyme to substrate proteins, thereby modulating substrate fate (often proteasomal degradation depending on ubiquitin chain topology). In the contexts retrieved here, RNF5 is repeatedly linked to proteasome-directed ubiquitination, particularly in ER quality control and innate immune adaptor turnover. (ge2024rnf5inhibitingantiviral pages 4-5, okiyoneda2024targetingubiquitinationmachinery pages 4-7)
ERAD is the principal pathway for disposing of misfolded or unassembled proteins in the endoplasmic reticulum. RNF5 is one of several ER membrane E3 ligases that recognize misfolded membrane proteins and initiate ubiquitination, targeting them for extraction and degradation by the proteasome. In CFTR biology, RNF5 is described as an ER-anchored E3 that detects folding/assembly defects at early biogenesis stages and contributes to degradation of misfolded CFTR variants such as F508del. (okiyoneda2024targetingubiquitinationmachinery pages 4-7, kamada2024herc3facilitateserad pages 1-2)
In antiviral innate immunity, adaptor proteins such as STING (MITA) and MAVS (VISA) drive type I interferon signaling. RNF5 is described as a negative regulator of these pathways by mediating ubiquitination and degradation of key adaptors (e.g., STING, MAVS) and downstream signaling proteins (e.g., IRF3 via recruitment mechanisms). (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 4-5)
Across multiple sources, RNF5 is described as ER-anchored/ER-embedded and membrane-associated, consistent with its principal roles in ERQC/ERAD and membrane-proximal innate signaling regulation. (okiyoneda2024targetingubiquitinationmachinery pages 4-7, kamada2024herc3facilitateserad pages 1-2)
CFTR-F508del is a misfolding-prone variant targeted for ERAD. RNF5 is described as recognizing folding/assembly defects in CFTR, including defects sensed at the N-terminus, and operating sequentially with CHIP (RNF5 early; CHIP later/post-translational) in monitoring CFTR folding status. (okiyoneda2024targetingubiquitinationmachinery pages 4-7)
Mechanistic placement supported by several sources:
- RNF5 contributes to ubiquitination of immature/core-glycosylated CFTR (Band B) rather than the mature plasma-membrane form (Band C), consistent with an early ER quality-control role. (riepe2024smallmoleculecorrectorsdivert pages 3-4)
- RNF5 was described as recognizing N-terminal regions/MSD1 and initiating ubiquitin chain formation that can be elongated by gp78/AMFR to facilitate ERAD. (kamada2024herc3facilitateserad pages 1-2)
- RNF5 shows redundancy/compensation with RNF185 (another ER membrane E3), which helps explain why single-gene perturbations can yield modest stabilization. (riepe2024smallmoleculecorrectorsdivert pages 3-4, okiyoneda2024targetingubiquitinationmachinery pages 11-13)
A 2024 review focused on RNF5 in antiviral signaling summarizes that RNF5 promotes ubiquitination and degradation of STING and MAVS, thereby inhibiting antiviral innate immunity. (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 4-5)
Residue-level details reported (from sources cited within the 2024 MI study’s mechanistic background and consistent with the innate-immunity review):
- STING/MITA targeted at K150 (degradative ubiquitination context). (wan2024ringfingerprotein pages 12-13, ge2024rnf5inhibitingantiviral pages 4-5)
- MAVS/VISA ubiquitination at K362 and K461 with proteasome-dependent degradation. (wan2024ringfingerprotein pages 12-13, ge2024rnf5inhibitingantiviral pages 4-5)
- Activated IRF3 can be degraded in a complex where JMJD6 recruits RNF5, as summarized in the innate-immunity-focused review. (ge2024rnf5inhibitingantiviral pages 4-5)
RNF5 has also been connected to autophagy regulation by controlling the stability of autophagy proteins. In the context of RNF5 inhibition strategies in CF, RNF5 inhibition (inh-2 and optimized analogues) is reported to increase basal autophagy, consistent with prior descriptions that RNF5 can promote ATG4B degradation and that RNF5 inhibitors interfere with this effect. (brusa2023innovativestrategytoward pages 9-11, brusa2023innovativestrategytoward pages 14-15)
A 2024 mouse/cardiomyocyte study proposes a cardioprotective role for RNF5, reporting that RNF5 downregulation occurs in infarcted heart tissue and that RNF5 knockout worsens myocardial infarction phenotypes, while RNF5 overexpression is protective; mechanistically, protection is attributed to inhibition of ASK1 activation (phosphorylation), though the directness of RNF5’s E3 action on ASK1 is not fully resolved in the provided excerpt. (wan2024ringfingerprotein pages 12-13)
A 2024 Molecular Biology of the Cell study performed genome-wide CRISPR/Cas9 screens to identify machinery driving CFTR-F508del ERAD.
- Scale: 20,528 genes screened; 207 high-confidence hits at FDR < 1%. (riepe2024smallmoleculecorrectorsdivert pages 3-4)
- Key result: RNF5 was the top E3 ligase hit, but RNF5 knockout only modestly reduced CFTR-F508del degradation, supporting robustness and redundancy. (riepe2024smallmoleculecorrectorsdivert pages 3-4, riepe2024smallmoleculecorrectorsdivert pages 1-2)
- Redundancy: secondary screens in an RNF5 knockout background identified RNF185 as a redundant ligase. (riepe2024smallmoleculecorrectorsdivert pages 3-4, okiyoneda2024targetingubiquitinationmachinery pages 11-13)
- Quantitative kinetics: CFTR-F508del reporter showed a degradation half-life of about 34 minutes in the reported system. (riepe2024smallmoleculecorrectorsdivert pages 3-4)
A schematic (Figure 4A) from this work summarizes sequential folding states and proposes that small-molecule correctors stabilize folding states that are not RNF5 substrates. (riepe2024smallmoleculecorrectorsdivert media 192d3a11)
A 2023 Journal of Medicinal Chemistry study advanced RNF5 inhibition as a CF strategy.
- Inhibitor scaffold: inh-2 (1,2,4-thiadiazol-5-ylidene) described as a first-in-class RNF5 inhibitor, with SAR leading to improved analogues including compound/analogue 16. (brusa2023innovativestrategytoward pages 14-15, brusa2023innovativestrategytoward pages 1-3)
- On-target validation: analogue 16 improved CFTR rescue in control (NT siRNA) cells but not in RNF5 siRNA cells, consistent with RNF5-dependent activity. (brusa2023innovativestrategytoward pages 11-14)
- Experimental concentrations (useful for real-world reproducibility): compounds commonly tested at 5 μM, with CFTR correctors used at VX-809 1–3 μM, VX-445 3 μM, and VX-661 + VX-445 10 μM + 3 μM; MG-132 used at 10 μM for ubiquitination assays. (brusa2023innovativestrategytoward pages 11-14)
- Autophagy link: analogue 16 increased basal autophagy, consistent with RNF5 inhibition phenotypes. (brusa2023innovativestrategytoward pages 11-14, brusa2023innovativestrategytoward pages 14-15)
A 2024 review focused on targeting ubiquitination machinery in CF notes that, despite long-standing interest, no compounds targeting ubiquitination have entered clinical trials for CF (at least as of June 2024 publication). (okiyoneda2024targetingubiquitinationmachinery pages 4-7)
The same review summarizes:
- RNF5 as an ER-anchored E3 that recognizes CFTR folding defects, pairs with E2 enzymes (e.g., UBE2J1), and acts sequentially with CHIP. (okiyoneda2024targetingubiquitinationmachinery pages 4-7)
- Preclinical results in which in vivo suppression of RNF5 in F508del-CFTR transgenic mice improved intestinal malabsorption and increased CFTR activity in intestinal epithelial cells. (okiyoneda2024targetingubiquitinationmachinery pages 4-7)
A 2024 Frontiers in Immunology review describes RNF5 as a key modulator of antiviral signaling and virus life cycle through ubiquitination of host innate-immune proteins (STING, MAVS, IRF3) and also viral proteins (notably in SARS-CoV-2 and KSHV contexts). (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 7-9)
The most concrete application in the retrieved corpus is RNF5 inhibition to stabilize immature F508del-CFTR and improve response to CFTR correctors.
- Real-world relevance: Over 80% of people with CF carry the F508del mutation, making the pathway broadly relevant to CF therapeutics. (riepe2024smallmoleculecorrectorsdivert pages 1-2)
- Implementation status: RNF5 inhibitors (inh-2, analogue 16) have been tested in airway epithelial models and in combination with clinically used correctors, but translation remains preclinical, and reviews emphasize lack of clinical trials targeting ubiquitination in CF. (okiyoneda2024targetingubiquitinationmachinery pages 4-7, brusa2023innovativestrategytoward pages 11-14)
RNF5 modulation (both inhibition and activation) is discussed as a strategy to shift antiviral signaling and/or viral replication steps, but this is currently largely mechanistic/preclinical in the provided corpus. (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 7-9)
RNF5 has been proposed as a cardioprotective regulator in myocardial infarction via the ASK1 pathway, based on genetic manipulation in mice and cardiomyocyte models; translation to therapy is not yet demonstrated in the provided evidence. (wan2024ringfingerprotein pages 12-13)
The 2024 CF ubiquitination review emphasizes both the appeal and difficulty of targeting ubiquitination: blocking ubiquitination to stabilize mutant CFTR has been considered for a long time, but progress has been slow and clinical translation has not yet occurred. It also highlights that approved corrector combinations (e.g., Trikafta/Kaftrio) demonstrate the effectiveness of pharmacological chaperone approaches that do not broadly interfere with cell signaling. (okiyoneda2024targetingubiquitinationmachinery pages 4-7)
The 2024 CRISPR screen study shows RNF5 is the top E3 hit for CFTR-F508del ERAD, but RNF5 loss produces only modest stabilization, consistent with redundant E3 ligase networks (RNF185 and others). This has practical implications: RNF5 inhibitors may need combination approaches or context-dependent use to yield clinically meaningful stabilization. (riepe2024smallmoleculecorrectorsdivert pages 3-4, okiyoneda2024targetingubiquitinationmachinery pages 11-13)
The 2024 RNF5 antiviral-immunity review frames RNF5 as a “novel means of modulating antiviral immunity,” emphasizing both host control mechanisms and viral exploitation of RNF5. This positions RNF5 as a plausible therapeutic lever, but also highlights pathway complexity and context-dependent outcomes. (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 7-9)
The following image provides a mechanistic synthesis of CFTR-F508del folding states and the proposed point at which RNF5-mediated ubiquitination targets early folding intermediates, while correctors stabilize RNF5-resistant states. (riepe2024smallmoleculecorrectorsdivert media 192d3a11)
Human RNF5 (UniProt Q99942) is best supported as an ER-embedded RING E3 ubiquitin ligase that (i) participates in ER quality control/ERAD of misfolded membrane proteins—most prominently CFTR-F508del—by acting at early biogenesis stages on immature ER-resident intermediates, in collaboration with specific E2 enzymes and partially redundant ER E3 ligases; and (ii) regulates innate immunity by promoting ubiquitination-dependent degradation of signaling adaptors such as STING and MAVS, thereby dampening antiviral interferon signaling; RNF5 also interfaces with autophagy regulation (e.g., ATG4B stability) and has emerging disease-model roles (e.g., ASK1 signaling in myocardial infarction). Recent 2023–2024 work positions RNF5 as an attractive but challenging therapeutic target because of network redundancy and the current gap between preclinical modulators (e.g., thiadiazole inhibitors) and clinical translation, particularly in cystic fibrosis. (ge2024rnf5inhibitingantiviral pages 5-7, okiyoneda2024targetingubiquitinationmachinery pages 4-7, riepe2024smallmoleculecorrectorsdivert pages 3-4, brusa2023innovativestrategytoward pages 11-14)
| Biological context/pathway | RNF5 molecular action | Key substrates/partners and specific lysines/linkages when available | Subcellular localization context | Recent 2023–2024 findings/applications with quantitative details | Primary supporting source |
|---|---|---|---|---|---|
| ERAD / proteostasis | RING E3 ubiquitin ligase; ubiquitinates immature membrane proteins for proteasomal ERAD | CFTR N-terminus/MSD1 recognized; partners include UBE2J1, UBE2D3, RNF185, gp78/AMFR, HERC3; acts mainly on immature CFTR Band B (okiyoneda2024targetingubiquitinationmachinery pages 4-7, riepe2024smallmoleculecorrectorsdivert pages 3-4, okiyoneda2024targetingubiquitinationmachinery pages 11-13, kamada2024herc3facilitateserad pages 1-2) | ER-anchored / ER-embedded membrane ligase with C-terminal TM region(s) (okiyoneda2024targetingubiquitinationmachinery pages 4-7, brusa2023innovativestrategytoward pages 9-11, kamada2024herc3facilitateserad pages 1-2) | Genome-wide CRISPR screen assayed 20,528 genes and found 207 high-confidence hits (FDR <1%); RNF5 was top E3 hit, UBE2D3 top E2; RNF5 KO had only modest effect, supporting pathway redundancy (riepe2024smallmoleculecorrectorsdivert pages 3-4) | Small-molecule correctors divert CFTR-F508del from ERAD by stabilizing sequential folding states (2024), https://doi.org/10.1091/mbc.e23-08-0336 |
| CFTR-F508del | Promotes ubiquitination and degradation of misfolded F508del-CFTR; early triage E3 in sequential ERQC | F508del-CFTR; sequential action with CHIP; RNF185 can compensate; correctors stabilize RNF5-resistant folding states (okiyoneda2024targetingubiquitinationmachinery pages 4-7, riepe2024smallmoleculecorrectorsdivert pages 3-4, okiyoneda2024targetingubiquitinationmachinery pages 11-13, riepe2024smallmoleculecorrectorsdivert media 192d3a11) | ER membrane / ERQC on nascent or immature CFTR before plasma-membrane maturation (okiyoneda2024targetingubiquitinationmachinery pages 4-7, riepe2024smallmoleculecorrectorsdivert pages 3-4, kamada2024herc3facilitateserad pages 1-2, riepe2024smallmoleculecorrectorsdivert media 192d3a11) | F508del occurs in >80% of people with CF / affects ~80% of CF patients worldwide; RNF5 suppression improved intestinal malabsorption and CFTR activity in F508del-transgenic mice; no RNF5-targeting compounds reported in clinical trials in the provided context (okiyoneda2024targetingubiquitinationmachinery pages 4-7, riepe2024smallmoleculecorrectorsdivert pages 1-2, brusa2023innovativestrategytoward pages 1-3) | Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? (2024), https://doi.org/10.1007/s00018-024-05295-z |
| CFTR-F508del therapeutic targeting | Pharmacologic RNF5 inhibition / degradation to reduce CFTR ubiquitination | inh-2 (first-in-class RNF5 inhibitor), analogue 16, FX12; analogue 16 effect lost with RNF5 siRNA, supporting on-target action (brusa2023innovativestrategytoward pages 11-14, brusa2023innovativestrategytoward pages 14-15, brusa2023innovativestrategytoward pages 1-3) | ER-associated RNF5 targeted indirectly by small molecules in airway epithelial cell models (brusa2023innovativestrategytoward pages 11-14, brusa2023innovativestrategytoward pages 14-15) | Compound testing commonly at 5 μM; VX-809 1–3 μM, VX-445 3 μM, VX-661 + VX-445 10 μM + 3 μM, MG-132 10 μM; analogue 16 was among the most promising compounds (11, 16, 21) and improved rescue with ELX/TEZ/IVA in CFBE41o− cells; FX12 active in BHK cells but not differentiated primary airway epithelia (brusa2023innovativestrategytoward pages 11-14, brusa2023innovativestrategytoward pages 14-15, okiyoneda2024targetingubiquitinationmachinery pages 4-7) | Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5 (2023), https://doi.org/10.1021/acs.jmedchem.3c00608 |
| Innate immunity: cGAS-STING / MAVS / IRF3 | E3 ligase that mainly promotes degradative ubiquitination of antiviral signaling adaptors; K48 linked for STING/MAVS in mammalian studies summarized in review | STING/MITA at K150 (K48-linked); MAVS/VISA at K362 and K461; activated IRF3 degraded after recruitment by JMJD6; viral proteins can hijack RNF5 and alter linkage usage (K27/K29/K63 also discussed in viral contexts) (wan2024ringfingerprotein pages 12-13, ge2024rnf5inhibitingantiviral pages 9-10, ge2024rnf5inhibitingantiviral pages 4-5) | ER-associated; MAVS regulation occurs in mitochondria-associated antiviral signaling context; STING at ER/ERGIC-associated innate immune membranes (ge2024rnf5inhibitingantiviral pages 9-10, ge2024rnf5inhibitingantiviral pages 4-5) | 2024 review emphasizes RNF5 as a negative regulator of antiviral innate immunity and a possible host-directed target; no clinical-stage RNF5 immune modulators reported in the provided context (ge2024rnf5inhibitingantiviral pages 5-7, ge2024rnf5inhibitingantiviral pages 9-10, ge2024rnf5inhibitingantiviral pages 4-5) | RNF5: inhibiting antiviral immunity and shaping virus life cycle (2024), https://doi.org/10.3389/fimmu.2023.1324516 |
| Autophagy | Regulates autophagy by targeting autophagy machinery components for degradation | ATG4B is a reported RNF5 substrate; inh-2 and analogue 16 increase basal autophagy consistent with blocking RNF5-mediated turnover; PTGDR2 can compete with ATG4B for RNF5 binding in gastric CSC context (brusa2023innovativestrategytoward pages 11-14, brusa2023innovativestrategytoward pages 9-11, brusa2023innovativestrategytoward pages 14-15) | ER-associated RNF5 with effects on cytosolic autophagy regulators (brusa2023innovativestrategytoward pages 9-11, brusa2023innovativestrategytoward pages 14-15) | Autophagy vacuoles increased with inh-2 and compounds 11/16/21; torin-1 used at 20 nM, SAR-405 at 2 μM in functional autophagy assays (brusa2023innovativestrategytoward pages 11-14) | Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5 (2023), https://doi.org/10.1021/acs.jmedchem.3c00608 |
| Cardiovascular | Protective E3-ligase-associated role in stress signaling; inhibits ASK1 pathway in MI model | ASK1 pathway implicated; whether direct ubiquitination of ASK1 is established was unresolved in provided context (wan2024ringfingerprotein pages 12-13) | Cardiac cells/tissue; RNF5 downregulated in infarcted mouse heart and OGD-treated cardiomyocytes (wan2024ringfingerprotein pages 12-13) | 2024 mouse/cell study: RNF5 knockout worsened myocardial infarction-associated dysfunction, inflammation, and apoptosis, while overexpression was protective; quantitative effect sizes not provided in context (wan2024ringfingerprotein pages 12-13) | RING finger protein 5 protects against acute myocardial infarction by inhibiting ASK1 (2024), https://doi.org/10.1186/s12872-024-04070-z |
| Oncology / other | Context-dependent E3 ligase affecting tumor signaling, proteostasis, and therapeutic response | EphA2/Eph receptors, paxillin, ATG4B; Open Targets links RNF5 to neoplasm, glioblastoma, ALL, cystic fibrosis, and EAE based on supporting literature (ge2024rnf5inhibitingantiviral pages 7-9, ge2024rnf5inhibitingantiviral pages 9-10, OpenTargets Search: -RNF5) | ER-associated ligase with downstream effects on signaling, migration, and transcriptional programs (ge2024rnf5inhibitingantiviral pages 7-9, ge2024rnf5inhibitingantiviral pages 9-10) | Open Targets evidence scores in provided context: cystic fibrosis association 0.4753, neoplasm 0.1277, glioblastoma 0.1098, ALL 0.1049, EAE 0.1039; preclinical therapeutic interest noted in AML, KSHV/PEL, and breast-cancer signaling, but no clinical trials reported here (OpenTargets Search: -RNF5, ge2024rnf5inhibitingantiviral pages 9-10) | Open Targets disease-target associations for RNF5 (accessed via provided context) (OpenTargets Search: -RNF5) |
Table: This table summarizes evidence-based functional annotation for human RNF5 (UniProt Q99942), organized by pathway context, molecular action, substrates, localization, and recent translational findings. It is useful as a compact reference for RNF5’s validated roles in ERAD, CFTR quality control, innate immunity, autophagy, cardiovascular biology, and disease associations.
References
(okiyoneda2024targetingubiquitinationmachinery pages 4-7): Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, Nicoletta Pedemonte, and Mauro Salvi. Targeting ubiquitination machinery in cystic fibrosis: where do we stand? Cellular and Molecular Life Sciences: CMLS, Jun 2024. URL: https://doi.org/10.1007/s00018-024-05295-z, doi:10.1007/s00018-024-05295-z. This article has 6 citations.
(brusa2023innovativestrategytoward pages 9-11): Irene Brusa, Elvira Sondo, Emanuela Pesce, Valeria Tomati, Dario Gioia, Federico Falchi, Beatrice Balboni, Jose Antonio Ortega Martínez, Marina Veronesi, Elisa Romeo, Natasha Margaroli, Maurizio Recanatini, Stefania Girotto, Nicoletta Pedemonte, Marinella Roberti, and Andrea Cavalli. Innovative strategy toward mutant cftr rescue in cystic fibrosis: design and synthesis of thiadiazole inhibitors of the e3 ligase rnf5. Journal of Medicinal Chemistry, 66:9797-9822, Jul 2023. URL: https://doi.org/10.1021/acs.jmedchem.3c00608, doi:10.1021/acs.jmedchem.3c00608. This article has 14 citations and is from a highest quality peer-reviewed journal.
(kamada2024herc3facilitateserad pages 1-2): Yuka Kamada, Yuko Ohnishi, Chikako Nakashima, Aika Fujii, Mana Terakawa, Ikuto Hamano, Uta Nakayamada, Saori Katoh, Noriaki Hirata, Hazuki Tateishi, Ryosuke Fukuda, Hirotaka Takahashi, Gergely L. Lukacs, and Tsukasa Okiyoneda. Herc3 facilitates erad of select membrane proteins by recognizing membrane-spanning domains. The Journal of Cell Biology, May 2024. URL: https://doi.org/10.1083/jcb.202308003, doi:10.1083/jcb.202308003. This article has 13 citations.
(ge2024rnf5inhibitingantiviral pages 4-5): Junyi Ge and Leiliang Zhang. Rnf5: inhibiting antiviral immunity and shaping virus life cycle. Frontiers in Immunology, Jan 2024. URL: https://doi.org/10.3389/fimmu.2023.1324516, doi:10.3389/fimmu.2023.1324516. This article has 9 citations and is from a peer-reviewed journal.
(ge2024rnf5inhibitingantiviral pages 5-7): Junyi Ge and Leiliang Zhang. Rnf5: inhibiting antiviral immunity and shaping virus life cycle. Frontiers in Immunology, Jan 2024. URL: https://doi.org/10.3389/fimmu.2023.1324516, doi:10.3389/fimmu.2023.1324516. This article has 9 citations and is from a peer-reviewed journal.
(riepe2024smallmoleculecorrectorsdivert pages 3-4): Celeste Riepe, Magda Wąchalska, Kirandeep K. Deol, Anais K. Amaya, Matthew H. Porteus, James A. Olzmann, and Ron R. Kopito. Small-molecule correctors divert cftr-f508del from erad by stabilizing sequential folding states. Molecular Biology of the Cell, Feb 2024. URL: https://doi.org/10.1091/mbc.e23-08-0336, doi:10.1091/mbc.e23-08-0336. This article has 10 citations and is from a domain leading peer-reviewed journal.
(okiyoneda2024targetingubiquitinationmachinery pages 11-13): Tsukasa Okiyoneda, Christian Borgo, Valentina Bosello Travain, Nicoletta Pedemonte, and Mauro Salvi. Targeting ubiquitination machinery in cystic fibrosis: where do we stand? Cellular and Molecular Life Sciences: CMLS, Jun 2024. URL: https://doi.org/10.1007/s00018-024-05295-z, doi:10.1007/s00018-024-05295-z. This article has 6 citations.
(wan2024ringfingerprotein pages 12-13): Hong Wan, Jianqing Zhang, Zhen Liu, Bizhen Dong, Zhangqian Tao, Guanglin Wang, and Chihua Wang. Ring finger protein 5 protects against acute myocardial infarction by inhibiting ask1. BMC Cardiovascular Disorders, Aug 2024. URL: https://doi.org/10.1186/s12872-024-04070-z, doi:10.1186/s12872-024-04070-z. This article has 4 citations and is from a peer-reviewed journal.
(brusa2023innovativestrategytoward pages 14-15): Irene Brusa, Elvira Sondo, Emanuela Pesce, Valeria Tomati, Dario Gioia, Federico Falchi, Beatrice Balboni, Jose Antonio Ortega Martínez, Marina Veronesi, Elisa Romeo, Natasha Margaroli, Maurizio Recanatini, Stefania Girotto, Nicoletta Pedemonte, Marinella Roberti, and Andrea Cavalli. Innovative strategy toward mutant cftr rescue in cystic fibrosis: design and synthesis of thiadiazole inhibitors of the e3 ligase rnf5. Journal of Medicinal Chemistry, 66:9797-9822, Jul 2023. URL: https://doi.org/10.1021/acs.jmedchem.3c00608, doi:10.1021/acs.jmedchem.3c00608. This article has 14 citations and is from a highest quality peer-reviewed journal.
(riepe2024smallmoleculecorrectorsdivert pages 1-2): Celeste Riepe, Magda Wąchalska, Kirandeep K. Deol, Anais K. Amaya, Matthew H. Porteus, James A. Olzmann, and Ron R. Kopito. Small-molecule correctors divert cftr-f508del from erad by stabilizing sequential folding states. Molecular Biology of the Cell, Feb 2024. URL: https://doi.org/10.1091/mbc.e23-08-0336, doi:10.1091/mbc.e23-08-0336. This article has 10 citations and is from a domain leading peer-reviewed journal.
(riepe2024smallmoleculecorrectorsdivert media 192d3a11): Celeste Riepe, Magda Wąchalska, Kirandeep K. Deol, Anais K. Amaya, Matthew H. Porteus, James A. Olzmann, and Ron R. Kopito. Small-molecule correctors divert cftr-f508del from erad by stabilizing sequential folding states. Molecular Biology of the Cell, Feb 2024. URL: https://doi.org/10.1091/mbc.e23-08-0336, doi:10.1091/mbc.e23-08-0336. This article has 10 citations and is from a domain leading peer-reviewed journal.
(brusa2023innovativestrategytoward pages 1-3): Irene Brusa, Elvira Sondo, Emanuela Pesce, Valeria Tomati, Dario Gioia, Federico Falchi, Beatrice Balboni, Jose Antonio Ortega Martínez, Marina Veronesi, Elisa Romeo, Natasha Margaroli, Maurizio Recanatini, Stefania Girotto, Nicoletta Pedemonte, Marinella Roberti, and Andrea Cavalli. Innovative strategy toward mutant cftr rescue in cystic fibrosis: design and synthesis of thiadiazole inhibitors of the e3 ligase rnf5. Journal of Medicinal Chemistry, 66:9797-9822, Jul 2023. URL: https://doi.org/10.1021/acs.jmedchem.3c00608, doi:10.1021/acs.jmedchem.3c00608. This article has 14 citations and is from a highest quality peer-reviewed journal.
(brusa2023innovativestrategytoward pages 11-14): Irene Brusa, Elvira Sondo, Emanuela Pesce, Valeria Tomati, Dario Gioia, Federico Falchi, Beatrice Balboni, Jose Antonio Ortega Martínez, Marina Veronesi, Elisa Romeo, Natasha Margaroli, Maurizio Recanatini, Stefania Girotto, Nicoletta Pedemonte, Marinella Roberti, and Andrea Cavalli. Innovative strategy toward mutant cftr rescue in cystic fibrosis: design and synthesis of thiadiazole inhibitors of the e3 ligase rnf5. Journal of Medicinal Chemistry, 66:9797-9822, Jul 2023. URL: https://doi.org/10.1021/acs.jmedchem.3c00608, doi:10.1021/acs.jmedchem.3c00608. This article has 14 citations and is from a highest quality peer-reviewed journal.
(ge2024rnf5inhibitingantiviral pages 7-9): Junyi Ge and Leiliang Zhang. Rnf5: inhibiting antiviral immunity and shaping virus life cycle. Frontiers in Immunology, Jan 2024. URL: https://doi.org/10.3389/fimmu.2023.1324516, doi:10.3389/fimmu.2023.1324516. This article has 9 citations and is from a peer-reviewed journal.
(OpenTargets Search: -RNF5): Open Targets Query (-RNF5, 38 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(ge2024rnf5inhibitingantiviral pages 9-10): Junyi Ge and Leiliang Zhang. Rnf5: inhibiting antiviral immunity and shaping virus life cycle. Frontiers in Immunology, Jan 2024. URL: https://doi.org/10.3389/fimmu.2023.1324516, doi:10.3389/fimmu.2023.1324516. This article has 9 citations and is from a peer-reviewed journal.
UniProt: Q99942 (RNF5_HUMAN), 180 aa, gene RNF5 / synonyms RMA1, NG2, G16. HGNC:10068. Chromosome 6 MHC class III region.
RNF5 is a membrane-anchored RING-type E3 ubiquitin ligase (EC 2.3.2.27). It has a C3HC4 RING domain (ZN_FING 27-68; catalytic Cys-42, mutation C42S abolishes ligase activity) and two C-terminal transmembrane helices (118-138, 160-180) that anchor it to the ER membrane (tail-anchored / multi-pass).
[file:human/RNF5/RNF5-uniprot.txt "Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins"]
[file:human/RNF5/RNF5-uniprot.txt "MUTAGEN 42 ... C->S: Loss of E3 ubiquitin-protein ligase activity"]
RNF5/RMA1 is one of the founding mammalian ER-associated E3 ligases for ERAD. It primes misfolded CFTR/CFTRdeltaF508 for degradation co-translationally, acting in an ER-membrane complex with the E2 Ubc6e and Derlin-1, upstream of/parallel to the cytosolic Hsc70/CHIP branch.
RNF5 and its paralog RNF185 form a partly redundant ERAD E3 module for CFTR; simultaneous depletion profoundly blocks CFTRdeltaF508 degradation. RNF5 interacts physically with RNF185 (IntAct).
RNF5 works with UBE2D (UbcH5) family E2s and can use Ubc13 (UBE2N) for K63 chains. It builds K48 chains on CFTR (degradative) and K63 chains on JAMP/JKAMP (non-degradative, regulatory).
PMID:19269966
PMID:19269966
[file:human/RNF5/RNF5-uniprot.txt "Mediates the 'Lys-63'-linked polyubiquitination of JKAMP thereby regulating JKAMP function by decreasing its association with components of the proteasome and ERAD; the ubiquitination appears to involve E2 ubiquitin-conjugating enzyme UBE2N"]
UniProt records Cell membrane (plasma membrane, PMID:9533025 early study), Mitochondrion membrane (PMID:19285439), and ER membrane (PMID:19285439). The functionally dominant ERAD location is the ER membrane. Plasma membrane and mitochondrial membrane localizations are real but reflect the original cloning paper and the antiviral/MITA study respectively. ER membrane is the core compartment for the ligase's ERAD function.
[file:human/RNF5/RNF5-uniprot.txt "Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}; Multi-pass membrane protein"]
Reviewed RNF5-deep-research-falcon.md (Edison/Falcon, 2026-06-12). Most content (ERAD/CFTR-F508del, STING/MAVS antiviral negative regulation, ATG4B/autophagy, RNF5/RNF185 redundancy) is already captured in this review. Genuinely new items:
ER proteostasis|...|ER associated degradation|Cytosolic handling of ERAD substrates|ERAD-associated RING E3 ligase; ALP|Autophagophore initiation and elongation|...|Modulation of ATG4 activity; UPS|E3 ubiquitin and UBL ligases|RING|with transmembrane domain|ER, mitochondria, cell membrane. PN-node mapping: ERAD-RING-E3 subtype→GO:0061630 (in_goa); ERAD type/group→GO:0036503 (in_goa); ATG4-modulation subtype→GO:2000785 regulation of autophagosome assembly (new_to_goa); RING group→GO:0061630 (in_goa). Projected: GO:0036503×2, GO:0061630×2 (all in GOA), GO:2000785 (new).This file is generated from the current PROTEOSTASIS phase-1 dossier and local gene-review artifacts. Edit the source review, PN mapping, or dossier rather than this generated note when correcting the underlying curation.
id: Q99942
gene_symbol: RNF5
product_type: PROTEIN
status: COMPLETE
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
RNF5 (RMA1, NG2/G16) is a small (180 aa) tail-anchored RING-type E3
ubiquitin-protein ligase (EC 2.3.2.27) embedded in the endoplasmic reticulum
membrane via two C-terminal transmembrane helices, with an N-terminal
cytosolic C3HC4 RING domain (catalytic Cys-42) that recruits ubiquitin-charged
E2 enzymes (notably the UBE2D/UbcH5 family and UBE2N/Ubc13). RNF5 is one of
the founding mammalian ER-anchored ERAD ubiquitin ligases. Together with the
E2 UBE2J1/Ubc6e and Derlin-1 it recognizes folding defects in membrane
proteins co-translationally and assembles K48-linked polyubiquitin chains that
commit misfolded clients such as CFTR and the disease-associated CFTR-deltaF508
mutant to retrotranslocation and proteasomal degradation; it functions partly
redundantly with its close paralog RNF185, with which it forms an E3 ligase
module central to CFTR degradation. Beyond canonical ERAD, RNF5 has documented
ligase-dependent regulatory roles that use distinct chain topologies and
substrates. It builds non-degradative K63-linked chains on the ERAD adaptor
JKAMP/JAMP to limit its recruitment of proteasome and p97/VCP components; it
ubiquitinates and degrades the innate-immune adaptor STING1/MITA at
mitochondria to dampen antiviral type I interferon responses; it controls
basal autophagy by regulating the stability of a membrane pool of the cysteine
protease ATG4B; and it ubiquitinates paxillin to influence cell motility. RNF5
is widely expressed, and although localized predominantly to membranes (with
reported plasma-membrane and mitochondrial-membrane pools), its ER-membrane
localization underlies its core ERAD ligase function.
existing_annotations:
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: Phylogenetic assignment of RING-type ubiquitin ligase activity, the core molecular function of RNF5, conserved across the RNF5/RNF185 family.
action: ACCEPT
reason: Core molecular function; supported experimentally (EC 2.3.2.27; C42S abolishes activity) and across the family.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: involved_in
review:
summary: Phylogenetic assignment of involvement in ER-associated degradation, the core biological process of RNF5 as an ER-anchored ERAD ligase.
action: ACCEPT
reason: Core biological process; directly supported by IMP evidence (CFTR/CFTR-deltaF508 degradation) and conserved in the family.
supported_by:
- reference_id: PMID:24019521
supporting_text: Cystic fibrosis transmembrane conductance regulator (CFTR) is one ERAD substrate targeted to co-translational degradation by the E3 ligase RNF5/RMA1
- term:
id: GO:0044390
label: ubiquitin-like protein conjugating enzyme binding
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: enables
review:
summary: RNF5 binds ubiquitin-conjugating (E2) enzymes, including the UBE2D/UbcH5 family and UBE2N/Ubc13, as part of its catalytic cycle. This is informative but ancillary to the ligase activity itself.
action: KEEP_AS_NON_CORE
reason: Accurately reflects E2 binding (UBE2D1/UBE2D2, UBE2N) required for catalysis, but is a mechanistic subsidiary of the core ubiquitin ligase activity.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: May function together with E2 ubiquitin-conjugating enzymes UBE2D1/UBCH5A and UBE2D2/UBC4
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: located_in
review:
summary: InterPro-based electronic assignment of ER localization, consistent with RNF5's ER-membrane site of ERAD function.
action: ACCEPT
reason: Correct compartment; redundant with the more specific ER membrane annotations and IDA (HPA) evidence.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}'
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Electronic transfer of ER membrane localization from the UniProt subcellular location; this is the core compartment for RNF5's ERAD ligase function.
action: ACCEPT
reason: Correct core localization; RNF5 is a tail-anchored ER membrane protein, supported experimentally (EXP, PMID:19285439).
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}'
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Electronic transfer of plasma membrane localization from the original cloning study (PMID:9533025). A real but secondary localization not tied to the core ERAD function.
action: KEEP_AS_NON_CORE
reason: Reported in the early cloning paper but the functionally dominant compartment for RNF5 is the ER membrane; plasma membrane pool is peripheral.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Cell membrane {ECO:0000269|PubMed:9533025}'
- term:
id: GO:0006511
label: ubiquitin-dependent protein catabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: InterPro-based electronic assignment of ubiquitin-dependent protein catabolism, a parent process consistent with RNF5's ERAD role.
action: ACCEPT
reason: Correct but generic; the specific GO:0036503 (ERAD pathway) better captures the core biological role.
supported_by:
- reference_id: PMID:24019521
supporting_text: degraded by the ubiquitin-proteasome pathway through a process called ER-associated degradation (ERAD)
- term:
id: GO:0031966
label: mitochondrial membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: Electronic transfer of mitochondrial membrane localization, reflecting the antiviral STING1/MITA study in which RNF5 acts at mitochondria. A real but secondary, immunity-related localization.
action: KEEP_AS_NON_CORE
reason: Supported by PMID:19285439 (MITA ubiquitination at mitochondria) but represents a secondary, context-specific role distinct from the core ER-membrane ERAD function.
supported_by:
- reference_id: PMID:19285439
supporting_text: virus-induced ubiquitination and degradation of MITA by RNF5 occurred at the mitochondria
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: ARBA machine-learning electronic assignment of the ERAD pathway, redundant with the experimentally supported core process.
action: ACCEPT
reason: Correct core biological process; redundant with IMP and IBA evidence.
supported_by:
- reference_id: PMID:24019521
supporting_text: Cystic fibrosis transmembrane conductance regulator (CFTR) is one ERAD substrate targeted to co-translational degradation by the E3 ligase RNF5/RMA1
- term:
id: GO:0044322
label: endoplasmic reticulum quality control compartment
evidence_type: IEA
original_reference_id: GO_REF:0000108
qualifier: located_in
review:
summary: Inter-ontology logical inference placing RNF5 in the ER quality control compartment, a plausible localization derived from its ERAD role.
action: KEEP_AS_NON_CORE
reason: Plausible localization inferred from the ERAD/ERQC link, but not directly demonstrated; the core localization annotation is ER membrane.
supported_by:
- reference_id: PMID:24019521
supporting_text: hosts a machinery called ERQC for ER quality control
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: enables
review:
summary: Combined automated electronic assignment of the core RING E3 ligase activity, consistent with EC 2.3.2.27 and experimental evidence.
action: ACCEPT
reason: Correct core molecular function; redundant with EXP/IBA evidence.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: EC=2.3.2.27
- term:
id: GO:1904380
label: endoplasmic reticulum mannose trimming
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: involved_in
review:
summary: ARBA machine-learning assignment of ER mannose trimming. RNF5 is a ubiquitin ligase and does not trim mannose; this is a pathway-adjacency over-annotation propagated from the ERAD/ERQC context.
action: REMOVE
reason: RNF5 has no glycosidase/mannosidase activity; mannose trimming is performed by EDEM/ER mannosidases, not by the E3 ligase. This electronic inference is biologically incorrect.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:12861019
qualifier: enables
review:
summary: IntAct interaction with paxillin (PXN), a functionally meaningful RNF5 substrate, but the bare protein binding term is uninformative.
action: KEEP_AS_NON_CORE
reason: Records a real substrate interaction (PXN) but bare protein binding is uninformative per curation guidelines.
supported_by:
- reference_id: PMID:12861019
supporting_text: the human homologue of RNF5 associates with the amino-terminal domain of paxillin
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:14667819
qualifier: enables
review:
summary: High-throughput yeast two-hybrid interactions (e.g. ABHD16A, UBE2 enzymes). Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Records real IntAct interactions but bare protein binding is uninformative and not a core function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; O95870: ABHD16A'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:16901789
qualifier: enables
review:
summary: Interaction with CFTR captured in the sequential-triage ERAD study; CFTR is a key RNF5 ERAD substrate. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Records the functionally important RNF5-CFTR interaction, but bare protein binding is uninformative; the substrate relationship is captured by the ERAD process annotations.
supported_by:
- reference_id: PMID:16901789
supporting_text: an ER membrane-associated ubiquitin ligase complex containing the E3 RMA1, the E2 Ubc6e, and Derlin-1
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19549727
qualifier: enables
review:
summary: E2 ubiquitin-conjugating enzyme interaction network capturing RNF5 binding to multiple UBE2D/UBE2E/UBE2W E2s. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Real E2 interactions relevant to catalysis but bare protein binding is uninformative; E2 binding is captured by GO:0044390.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; P51668: UBE2D1'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:20152160
qualifier: enables
review:
summary: Interaction with the E2 UBE2D2/UbcH5b from a structural study of the E2~Ub conjugate. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Real E2 interaction but bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; P62837: UBE2D2'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: Large-scale interactome map capturing numerous RNF5 partners (including SLC transporters, RNF185, SEC22A). Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: High-throughput interactome; bare protein binding is uninformative and not a core function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q96GF1: RNF185'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:25759021
qualifier: enables
review:
summary: Interactions with glutamine carrier proteins (SLC1A5, SLC38A2) relevant to RNF5's role in breast cancer ER-stress response. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Records real substrate/carrier interactions but bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q15758: SLC1A5'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26618866
qualifier: enables
review:
summary: Interaction with CFTR from a deltaF508 CFTR interactome-remodeling study. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Real CFTR interaction relevant to ERAD but bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; P13569: CFTR'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:31515488
qualifier: enables
review:
summary: Interaction captured in a study of variant-driven interactome disruption. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: High-throughput interaction; bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q969T4: UBE2E3'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: Binary interactome reference map capturing many RNF5 membrane-protein partners. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: High-throughput interactome; bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q9Y5U4: INSIG2'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: Interactions (e.g. OPTN, UBE2K) from a neurodegenerative-disease interactome study. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: High-throughput interaction; bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q96CV9: OPTN'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: Cell-specific interactome capturing RNF5 partners including RNF185 and RHBDD1. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: High-throughput interactome; bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q96GF1: RNF185'
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:36012204
qualifier: enables
review:
summary: Proximity-labeling interaction with CFTR identifying enrichment in SLC transporters. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Real CFTR/SLC interactions but bare protein binding is uninformative.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; P13569: CFTR'
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:25416956
qualifier: enables
review:
summary: RNF5 self-interaction captured in a proteome-scale interactome. Reflects homo-association seen in screens.
action: KEEP_AS_NON_CORE
reason: Documents RNF5 self-association (IntAct EBI-348482 with itself) but is peripheral to the core ligase function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q99942: RNF5'
- term:
id: GO:0042802
label: identical protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: RNF5 self-interaction captured in the binary interactome reference map.
action: KEEP_AS_NON_CORE
reason: Documents RNF5 self-association but is peripheral to the core ligase function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Q99942; Q99942: RNF5'
- term:
id: GO:0016020
label: membrane
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: located_in
review:
summary: Ortholog-based electronic assignment of generic membrane localization, a parent of the specific ER membrane localization.
action: KEEP_AS_NON_CORE
reason: Correct but generic; subsumed by the more specific ER membrane localization.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Multi-pass membrane protein
- term:
id: GO:0055085
label: transmembrane transport
evidence_type: TAS
original_reference_id: Reactome:R-HSA-382556
qualifier: involved_in
review:
summary: Reactome pathway-level annotation (ABC-family transport). RNF5 is a ubiquitin ligase, not a transporter; this reflects pathway context (CFTR/ABC transport) bleed-through.
action: REMOVE
reason: RNF5 does not mediate transmembrane transport; it is an E3 ligase acting on transporter substrates such as CFTR. The transport annotation is a pathway-adjacency artifact, not a direct function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
- term:
id: GO:0016567
label: protein ubiquitination
evidence_type: IEA
original_reference_id: GO_REF:0000041
qualifier: involved_in
review:
summary: UniPathway-derived general protein ubiquitination process, a parent of the specific ERAD-associated ubiquitination RNF5 performs.
action: KEEP_AS_NON_CORE
reason: Correct but generic; the specific ERAD pathway and K48/K63 ubiquitination annotations better capture the role.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'PATHWAY: Protein modification; protein ubiquitination.'
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866546
qualifier: enables
review:
summary: Reactome curation of RNF5 (with RNF185) ubiquitinating misfolded CFTR; captures the core ligase activity.
action: ACCEPT
reason: Correct core molecular function in the CFTR ERAD reaction.
supported_by:
- reference_id: PMID:24019521
supporting_text: identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8867288
qualifier: enables
review:
summary: Reactome curation of the ERAD E3 ligase ubiquitinating an unfolded glycoprotein substrate; captures the core ligase activity.
action: ACCEPT
reason: Correct core molecular function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
- term:
id: GO:0005783
label: endoplasmic reticulum
evidence_type: IDA
original_reference_id: GO_REF:0000052
qualifier: located_in
review:
summary: Direct immunofluorescence (HPA) evidence for ER localization, consistent with RNF5's ER-membrane ERAD function.
action: ACCEPT
reason: IDA-supported ER localization agrees with the documented ER-membrane site of action.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Endoplasmic reticulum membrane {ECO:0000269|PubMed:19285439}'
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: EXP
original_reference_id: PMID:19285439
qualifier: located_in
review:
summary: Experimental evidence that RNF5 localizes to the ER membrane; the core compartment for its ERAD ligase activity.
action: ACCEPT
reason: Core localization with direct experimental support.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005886
label: plasma membrane
evidence_type: EXP
original_reference_id: PMID:9533025
qualifier: located_in
review:
summary: Experimental localization to the plasma membrane reported in the original cloning study. A real but secondary localization.
action: KEEP_AS_NON_CORE
reason: Documented in the cloning paper but the functionally dominant compartment is the ER membrane; plasma-membrane pool is peripheral to the core ERAD role.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: 'Predominantly located in the plasma membrane, with some localization occurring within cytoplasmic organelles'
- term:
id: GO:0031966
label: mitochondrial membrane
evidence_type: EXP
original_reference_id: PMID:19285439
qualifier: located_in
review:
summary: Experimental localization to the mitochondrial membrane, where RNF5 ubiquitinates STING1/MITA during antiviral responses. A real but secondary, immunity-related localization.
action: KEEP_AS_NON_CORE
reason: Directly supported (PMID:19285439) but a secondary compartment for a context-specific immune role, not the core ER ERAD function.
supported_by:
- reference_id: PMID:19285439
supporting_text: virus-induced ubiquitination and degradation of MITA by RNF5 occurred at the mitochondria
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: EXP
original_reference_id: PMID:19269966
qualifier: enables
review:
summary: Experimental demonstration of RNF5 ubiquitin ligase activity (RING-dependent ubiquitination of JAMP). Core molecular function.
action: ACCEPT
reason: Core molecular function with direct experimental support; WT but not RING-mutant RNF5 ubiquitinates substrate.
supported_by:
- reference_id: PMID:19269966
supporting_text: Ectopically expressed JAMP was efficiently ubiquitinated in vivo by WT but not the RING mutant form of RNF5
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: EXP
original_reference_id: PMID:19285439
qualifier: enables
review:
summary: Experimental demonstration of RNF5 ligase activity ubiquitinating STING1/MITA. Core molecular function.
action: ACCEPT
reason: Core molecular function with direct experimental support.
supported_by:
- reference_id: PMID:19285439
supporting_text: RNF5 targeted MITA at Lys150 for ubiquitination and degradation after viral infection
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: EXP
original_reference_id: PMID:23093945
qualifier: enables
review:
summary: Experimental demonstration of RNF5 ligase activity controlling ATG4B ubiquitination and stability. Core molecular function.
action: ACCEPT
reason: Core molecular function with direct experimental support.
supported_by:
- reference_id: PMID:23093945
supporting_text: the membrane-associated E3 ligase RNF5 regulates basal levels of autophagy by controlling the stability of a select pool of the cysteine protease ATG4B
- term:
id: GO:0006511
label: ubiquitin-dependent protein catabolic process
evidence_type: IGI
original_reference_id: PMID:24019521
qualifier: involved_in
review:
summary: Genetic-interaction evidence (with RNF185) that RNF5 drives ubiquitin-dependent degradation of CFTR; redundant depletion blocks CFTR-deltaF508 turnover.
action: ACCEPT
reason: Supported by the RNF5/RNF185 co-depletion experiments; consistent with the core ERAD/proteasomal degradation role.
supported_by:
- reference_id: PMID:24019521
supporting_text: simultaneous depletion of RNF5 and RNF185 profoundly blocks CFTRΔF508 degradation not only during translation but also after synthesis is complete
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IMP
original_reference_id: PMID:24019521
qualifier: involved_in
review:
summary: Mutant-phenotype evidence that RNF5 is required for ERAD of CFTR/CFTR-deltaF508. Core biological process.
action: ACCEPT
reason: Core biological process with direct experimental (IMP) support from depletion experiments.
supported_by:
- reference_id: PMID:24019521
supporting_text: simultaneous depletion of RNF5 and RNF185 profoundly blocks CFTRΔF508 degradation
- term:
id: GO:0061630
label: ubiquitin protein ligase activity
evidence_type: TAS
original_reference_id: PMID:24019521
qualifier: enables
review:
summary: Author statement of RNF5 ubiquitin ligase activity in CFTR ERAD. Core molecular function.
action: ACCEPT
reason: Correct core molecular function.
supported_by:
- reference_id: PMID:24019521
supporting_text: targeted to co-translational degradation by the E3 ligase RNF5/RMA1
- term:
id: GO:1904380
label: endoplasmic reticulum mannose trimming
evidence_type: TAS
original_reference_id: Reactome:R-HSA-901032
qualifier: involved_in
review:
summary: Reactome ERQC pathway annotation. RNF5 does not perform mannose trimming; this is pathway-adjacency over-annotation.
action: REMOVE
reason: RNF5 is an E3 ligase with no mannosidase activity; ER mannose trimming is carried out by ER mannosidases/EDEMs. The annotation conflates pathway membership with direct activity.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: Membrane-bound E3 ubiquitin-protein ligase that mediates ubiquitination of target proteins
- term:
id: GO:0044877
label: protein-containing complex binding
evidence_type: IPI
original_reference_id: PMID:24019521
qualifier: enables
review:
summary: RNF5 binds a protein complex (ERAD machinery) in the CFTR degradation study. More informative than bare protein binding but still ancillary.
action: KEEP_AS_NON_CORE
reason: Reflects association with the ERAD E3 module/machinery; supportive of, but subsidiary to, the core ligase and ERAD-process annotations.
supported_by:
- reference_id: PMID:24019521
supporting_text: identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866542
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization within CFTR ERAD reactions. Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866546
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (RNF5/RNF185 ubiquitinate misfolded CFTR). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866551
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (CFTR binds ERAD machinery). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866854
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (CFTR F508del translocation). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866856
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (RNF5/RNF185 ubiquitinate CFTR F508del). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8866857
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (CFTR F508del binds ERAD machinery). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-8867288
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization in an ERAD ubiquitination reaction. Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931264
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (CD274/PD-L1 ERAD transport). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931298
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (ubiquitination of CD274 by ERAD complex). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005789
label: endoplasmic reticulum membrane
evidence_type: TAS
original_reference_id: Reactome:R-HSA-9931313
qualifier: located_in
review:
summary: Reactome curation of RNF5 ER membrane localization (p-CD274 binds ERAD complex). Core compartment.
action: ACCEPT
reason: Correct core localization; redundant with experimental evidence.
supported_by:
- reference_id: PMID:19285439
supporting_text: Both MITA and RNF5 were located at the mitochondria and endoplasmic reticulum (ER)
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:24019521
qualifier: enables
review:
summary: Interaction captured in the RNF185/RNF5 CFTR ERAD study. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Real interaction within the ERAD module but bare protein binding is uninformative.
supported_by:
- reference_id: PMID:24019521
supporting_text: identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
- term:
id: GO:0030163
label: protein catabolic process
evidence_type: IMP
original_reference_id: PMID:19285439
qualifier: involved_in
review:
summary: Mutant-phenotype evidence that RNF5 drives degradation of a target protein (STING1/MITA). A parent of the more specific ubiquitin-dependent catabolic/ERAD process.
action: KEEP_AS_NON_CORE
reason: Correct but generic relative to the specific ERAD and K48-ubiquitination annotations; here the catabolic target is the immune adaptor MITA.
supported_by:
- reference_id: PMID:19285439
supporting_text: RNF5 targeted MITA at Lys150 for ubiquitination and degradation after viral infection
- term:
id: GO:0070936
label: protein K48-linked ubiquitination
evidence_type: IDA
original_reference_id: PMID:19285439
qualifier: involved_in
review:
summary: Direct evidence that RNF5 builds K48-linked polyubiquitin chains (degradative topology) on STING1/MITA. This degradative topology is also used on CFTR.
action: ACCEPT
reason: Directly demonstrated K48-linked ubiquitination, the canonical degradative topology underlying RNF5's ERAD and MITA-degradation roles.
supported_by:
- reference_id: PMID:19269966
supporting_text: CFTR ubiquitination occurred at the canonical Lys-48 topology
- term:
id: GO:0004842
label: ubiquitin-protein transferase activity
evidence_type: IDA
original_reference_id: PMID:19269966
qualifier: enables
review:
summary: Direct evidence of ubiquitin-protein transferase activity, a parent of the specific RING-type ubiquitin ligase activity.
action: ACCEPT
reason: Correct general molecular function; the specific GO:0061630 captures the RING E3 ligase activity.
supported_by:
- reference_id: PMID:19269966
supporting_text: Ectopically expressed JAMP was efficiently ubiquitinated in vivo by WT but not the RING mutant form of RNF5
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:19269966
qualifier: enables
review:
summary: Interaction with JKAMP/JAMP, a functionally important RNF5 substrate/partner at the ER membrane. Bare protein binding is uninformative.
action: KEEP_AS_NON_CORE
reason: Records the real RNF5-JAMP interaction but bare protein binding is uninformative.
supported_by:
- reference_id: PMID:19269966
supporting_text: RNF5 associates with JAMP in the ER membrane
- term:
id: GO:0036503
label: ERAD pathway
evidence_type: IMP
original_reference_id: PMID:19269966
qualifier: involved_in
review:
summary: Mutant-phenotype evidence linking RNF5 to ERAD, here via regulation of the ERAD adaptor JAMP. Core biological process.
action: ACCEPT
reason: Core biological process; RNF5 modulates ERAD both by direct substrate ubiquitination and by K63-regulation of JAMP.
supported_by:
- reference_id: PMID:19269966
supporting_text: RNF5 is a ubiquitin ligase anchored to the ER membrane implicated in ERAD via ubiquitination of misfolded proteins
- term:
id: GO:0070534
label: protein K63-linked ubiquitination
evidence_type: IDA
original_reference_id: PMID:19269966
qualifier: involved_in
review:
summary: Direct evidence that RNF5 builds non-degradative K63-linked polyubiquitin chains on JAMP (Ubc13/UBE2N-dependent), a regulatory rather than degradative modification.
action: ACCEPT
reason: Directly demonstrated K63-linked ubiquitination, establishing RNF5's capacity for non-canonical regulatory ubiquitination distinct from K48 degradative chains.
supported_by:
- reference_id: PMID:19269966
supporting_text: These findings establish that RNF5 mediates Lys-63-based polyubiquitination of JAMP
- term:
id: GO:0008270
label: zinc ion binding
evidence_type: TAS
original_reference_id: PMID:9533025
qualifier: enables
review:
summary: The C3HC4 RING domain coordinates zinc as a structural requirement for the ligase fold. A structural attribute supporting, not equal to, the ligase activity.
action: KEEP_AS_NON_CORE
reason: Accurate structural feature of the RING domain (residues 27-68) but subsidiary to the informative ubiquitin ligase activity; not a standalone core function.
supported_by:
- reference_id: file:human/RNF5/RNF5-uniprot.txt
supporting_text: RING-type
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000041
title: Gene Ontology annotation based on UniPathway vocabulary mapping
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
findings: []
- id: GO_REF:0000052
title: Gene Ontology annotation based on curation of immunofluorescence data
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000108
title: Automatic assignment of GO terms using logical inference, based on inter-ontology links
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: PMID:12861019
title: RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization.
findings:
- statement: RNF5 associates with the N-terminal domain of paxillin and mediates its ubiquitination, requiring intact RING and C-terminal domains, regulating cell motility.
reference_section_type: ABSTRACT
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Establishes a non-core cell-motility role via paxillin ubiquitination; the source of the GO:0005515 PXN interaction.
- id: PMID:14667819
title: Analysis of a high-throughput yeast two-hybrid system and its use to predict the function of intracellular proteins encoded within the human MHC class III region.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: High-throughput Y2H interactome (MHC class III region); source of several bare protein binding annotations.
- id: PMID:16901789
title: Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.
findings:
- statement: An ER membrane-associated ubiquitin ligase complex of E3 RMA1/RNF5, E2 Ubc6e and Derlin-1 recognizes folding defects in CFTR/CFTR-deltaF508 co-translationally and cooperates with cytosolic Hsc70/CHIP to promote proteasomal degradation.
reference_section_type: ABSTRACT
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Foundational study establishing RNF5/RMA1 as a co-translational ER-membrane ERAD ligase for CFTR.
- id: PMID:19269966
title: Regulation of endoplasmic reticulum-associated degradation by RNF5-dependent ubiquitination of JNK-associated membrane protein (JAMP).
findings:
- statement: RNF5 builds Ubc13(UBE2N)-dependent K63-linked polyubiquitin chains on the ERAD adaptor JAMP at the ER membrane, reducing JAMP association with proteasome subunits and p97/VCP and thereby limiting ERAD; RNF5 builds canonical K48 chains on CFTR.
reference_section_type: RESULTS
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full text available; demonstrates RNF5 RING-dependent ligase activity and distinct K48 (CFTR) vs K63 (JAMP) chain topologies.
- id: PMID:19285439
title: The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA.
findings:
- statement: RNF5 interacts with STING1/MITA in a virus-infection-dependent manner and builds K48-linked chains on MITA at Lys150 for proteasomal degradation at mitochondria, negatively regulating type I interferon antiviral responses; RNF5 localizes at ER and mitochondria.
reference_section_type: ABSTRACT
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes the non-core antiviral/immunity role and mitochondrial localization; source of K48 ubiquitination and mitochondrial-membrane annotations.
- id: PMID:19549727
title: Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: E2 interaction network; documents RNF5 binding to multiple UBE2D/UBE2E/UBE2W enzymes relevant to its catalytic cycle.
- id: PMID:20152160
title: 'Crystal structure of UbcH5b~ubiquitin intermediate: insight into the formation of the self-assembled E2~Ub conjugates.'
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Structural E2~Ub study; captures RNF5-UBE2D2 interaction.
- id: PMID:23093945
title: Regulation of ATG4B stability by RNF5 limits basal levels of autophagy and influences susceptibility to bacterial infection.
findings:
- statement: RNF5 regulates basal autophagy by controlling the stability of a membrane pool of the cysteine protease ATG4B, thereby limiting LC3/ATG8 processing required for autophagosome formation.
reference_section_type: ABSTRACT
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Establishes the non-core autophagy-regulatory role via ATG4B; provides EXP support for ligase activity.
- id: PMID:24019521
title: RNF185 is a novel E3 ligase of endoplasmic reticulum-associated degradation (ERAD) that targets cystic fibrosis transmembrane conductance regulator (CFTR).
findings:
- statement: RNF185 and RNF5 form a partly redundant E3 ligase module central to CFTR/CFTR-deltaF508 degradation; co-depletion profoundly blocks CFTR-deltaF508 degradation during and after translation.
reference_section_type: ABSTRACT
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: Full text available; establishes RNF5/RNF185 redundancy in CFTR ERAD; source of IMP/IGI ERAD annotations.
- id: PMID:25416956
title: A proteome-scale map of the human interactome network.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: High-throughput interactome; source of multiple bare protein binding and identical protein binding (self) annotations.
- id: PMID:25759021
title: Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies.
findings:
- statement: RNF5 regulates glutamine carrier proteins (SLC1A5, SLC38A2) under ER stress, influencing breast cancer response to chemotherapy.
reference_section_type: ABSTRACT
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Non-core cancer/ER-stress role; source of SLC transporter interactions.
- id: PMID:26618866
title: ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: CFTR-deltaF508 interactome study; captures RNF5-CFTR interaction relevant to ERAD.
- id: PMID:31515488
title: Extensive disruption of protein interactions by genetic variants across the allele frequency spectrum in human populations.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: High-throughput variant-interactome study; source of a bare protein binding annotation.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Binary interactome reference map; source of multiple bare protein binding and self-interaction annotations.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Neurodegeneration interactome; source of bare protein binding annotations (e.g. OPTN, UBE2K).
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: Cell-specific interactome; source of bare protein binding annotations (RNF185, RHBDD1).
- id: PMID:36012204
title: Differential CFTR-Interactome Proximity Labeling Procedures Identify Enrichment in Multiple SLC Transporters.
findings: []
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: CFTR proximity-labeling interactome; captures RNF5-CFTR interaction relevant to ERAD.
- id: PMID:9533025
title: Cloning, expression and mapping of a novel RING-finger gene (RNF5), a human homologue of a putative zinc-finger gene from Caenorhabditis elegans.
findings:
- statement: Original cloning of RNF5, a RING-finger gene in the MHC class III region; reported widespread expression and predominantly plasma-membrane localization with some cytoplasmic-organelle localization.
reference_section_type: ABSTRACT
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: Original cloning/characterization; source of zinc ion binding (TAS) and plasma-membrane localization annotations.
- id: Reactome:R-HSA-382556
title: ABC-family proteins mediated transport
findings: []
- id: Reactome:R-HSA-8866542
title: VCP-catalyzed ATP hydrolysis promotes the translocation of misfolded CFTR into the cytosol
findings: []
- id: Reactome:R-HSA-8866546
title: RNF5 and RNF185 ubiquitinate misfolded CFTR
findings: []
- id: Reactome:R-HSA-8866551
title: CFTR binds components of the ERAD machinery for ubiquitination and degradation
findings: []
- id: Reactome:R-HSA-8866854
title: VCP-catalyzed ATP hydrolysis promotes the translocation of CFTR F508del into the cytosol
findings: []
- id: Reactome:R-HSA-8866856
title: RNF5 and RNF185 ubiquitinate CFTR F508del
findings: []
- id: Reactome:R-HSA-8866857
title: CFTR F508del binds components of the ERAD machinery for ubiquitination and degradation
findings: []
- id: Reactome:R-HSA-8867288
title: OS9:SEL1:ERAD E3 ligase:DERL2 ubiquitinates unfolded protein:(GlcNAc)2 (Man)9-5
findings: []
- id: Reactome:R-HSA-901032
title: ER Quality Control Compartment (ERQC)
findings: []
- id: Reactome:R-HSA-9931264
title: Active transport of ubiquitinated CD274 from ER to cytosol
findings: []
- id: Reactome:R-HSA-9931298
title: Ubiquitination of CD274 by ERAD complex
findings: []
- id: Reactome:R-HSA-9931313
title: p-S195-CD274 binds ERAD complex
findings: []
- id: PMID:39098896
title: RING finger protein 5 protects against acute myocardial infarction by inhibiting ASK1.
findings:
- statement: RNF5 is downregulated in infarcted heart tissue; RNF5 knockout worsens and RNF5 overexpression ameliorates myocardial infarction injury in mouse and cardiomyocyte models, with protection attributed to inhibition of ASK1 (MAP3K5) activation.
reference_section_type: ABSTRACT
reference_review:
relevance: MEDIUM
correctness: VERIFIED
review_notes: PubMed-verified (PMID:39098896 = BMC Cardiovasc Disord 2024, DOI 10.1186/s12872-024-04070-z); proposes a non-core cardioprotective role for RNF5 via the ASK1 stress-signaling pathway. Directness of RNF5 E3 action on ASK1 not fully resolved; full text not in cache, so no supporting_text added to annotations.
core_functions:
- description: RING-type E3 ubiquitin ligase anchored in the ER membrane that ubiquitinates misfolded membrane-protein clients (e.g. CFTR and CFTR-deltaF508) with K48-linked chains to commit them to retrotranslocation and proteasomal degradation via the ERAD pathway, acting partly redundantly with RNF185.
molecular_function:
id: GO:0061630
label: ubiquitin protein ligase activity
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:16901789
supporting_text: an ER membrane-associated ubiquitin ligase complex containing the E3 RMA1, the E2 Ubc6e, and Derlin-1
- reference_id: PMID:24019521
supporting_text: identify RNF185 and RNF5 as a novel E3 ligase module that is central to the control of CFTR degradation
directly_involved_in:
- id: GO:0036503
label: ERAD pathway
- description: ER-membrane ubiquitin ligase that builds non-degradative K63-linked polyubiquitin chains on the ERAD adaptor JKAMP/JAMP (UBE2N/Ubc13-dependent), modulating its recruitment of proteasome and p97/VCP components and thereby regulating ERAD flux.
molecular_function:
id: GO:0061630
label: ubiquitin protein ligase activity
locations:
- id: GO:0005789
label: endoplasmic reticulum membrane
supported_by:
- reference_id: PMID:19269966
supporting_text: These findings establish that RNF5 mediates Lys-63-based polyubiquitination of JAMP
directly_involved_in:
- id: GO:0070534
label: protein K63-linked ubiquitination
proposed_new_terms: []
suggested_questions:
- question: What determines RNF5 substrate selectivity and chain-topology choice (K48 degradative on CFTR/MITA vs K63 regulatory on JAMP), and which E2 partner (UBE2D vs UBE2N) is decisive in each case?
- question: To what extent are RNF5's antiviral (STING1/MITA) and autophagy (ATG4B) roles separable from its core ER ERAD function, and do they require distinct subcellular pools?
suggested_experiments:
- description: Reconstitute ERAD ubiquitination of CFTR-deltaF508 in vitro with purified RNF5, RNF185, UBE2J1/Ubc6e and Derlin-1 to map lysine sites and ubiquitin-chain linkage on the substrate and to dissect RNF5/RNF185 redundancy.
- description: Generate RNF5 and RNF5/RNF185 double-knockout cells and perform quantitative ubiquitinome/proteome profiling under basal and ER-stress conditions to define the endogenous ERAD substrate repertoire and the degree of paralog redundancy.